# Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

> **NCT07305324** · NA · NOT_YET_RECRUITING · sponsor: **Yale University** · enrollment: 40 (estimated)

## Conditions studied

- MASLD
- Fibrosis of Liver

## Interventions

- **DEVICE:** FibroX
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07305324
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-05-15
- **Final completion:** 2027-06-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305324, "Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07305324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*